These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 28584141)

  • 21. Successful selection of an infection-protective anti-Staphylococcus aureus monoclonal antibody and its protective activity in murine infection models.
    Ohsawa H; Baba T; Enami J; Hiramatsu K
    Microbiol Immunol; 2015 Apr; 59(4):183-92. PubMed ID: 25659598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Alpha Toxin To Mitigate Its Lethal Toxicity in Ferret and Rabbit Models of Staphylococcus aureus Necrotizing Pneumonia.
    Diep BA; Hilliard JJ; Le VT; Tkaczyk C; Le HN; Tran VG; Rao RL; Dip EC; Pereira-Franchi EP; Cha P; Jacobson S; Broome R; Cheng LI; Weiss W; Prokai L; Nguyen V; Stover CK; Sellman BR
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant.
    Josefsson E; Hartford O; O'Brien L; Patti JM; Foster T
    J Infect Dis; 2001 Dec; 184(12):1572-80. PubMed ID: 11740733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus α-hemolysin.
    Foletti D; Strop P; Shaughnessy L; Hasa-Moreno A; Casas MG; Russell M; Bee C; Wu S; Pham A; Zeng Z; Pons J; Rajpal A; Shelton D
    J Mol Biol; 2013 May; 425(10):1641-54. PubMed ID: 23416200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isotype switching increases efficacy of antibody protection against staphylococcal enterotoxin B-induced lethal shock and Staphylococcus aureus sepsis in mice.
    Varshney AK; Wang X; Aguilar JL; Scharff MD; Fries BC
    mBio; 2014 Jun; 5(3):e01007-14. PubMed ID: 24917594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutralizing Alpha-Toxin Accelerates Healing of Staphylococcus aureus-Infected Wounds in Nondiabetic and Diabetic Mice.
    Ortines RV; Liu H; Cheng LI; Cohen TS; Lawlor H; Gami A; Wang Y; Dillen CA; Archer NK; Miller RJ; Ashbaugh AG; Pinsker BL; Marchitto MC; Tkaczyk C; Stover CK; Sellman BR; Miller LS
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311091
    [No Abstract]   [Full Text] [Related]  

  • 27. Identification and characterization of antigenic epitope of Staphylococcus aureus ClfA adhesin.
    Li Y; Liu YH; Li ZJ; Li YG; Liu MY; Liu LB; Wang XG; Wang XL; Suo J; Han WY
    Res Vet Sci; 2013 Jun; 94(3):490-5. PubMed ID: 23178048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia.
    Ragle BE; Bubeck Wardenburg J
    Infect Immun; 2009 Jul; 77(7):2712-8. PubMed ID: 19380475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staphylococcus aureus α-Toxin Response Distinguishes Respiratory Virus-Methicillin-Resistant S. aureus Coinfection in Children.
    Yu KO; Randolph AG; Agan AA; Yip WK; Truemper EJ; Weiss SL; Ackerman KG; Schwarz AJ; Giuliano JS; Hall MW; Bubeck Wardenburg J; ;
    J Infect Dis; 2016 Dec; 214(11):1638-1646. PubMed ID: 27651418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lessons from the Crystal Structure of the S. aureus Surface Protein Clumping Factor A in Complex With Tefibazumab, an Inhibiting Monoclonal Antibody.
    Ganesh VK; Liang X; Geoghegan JA; Cohen ALV; Venugopalan N; Foster TJ; Hook M
    EBioMedicine; 2016 Nov; 13():328-338. PubMed ID: 27789272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimechanistic Monoclonal Antibody Combination Targeting Key Staphylococcus aureus Virulence Determinants in a Rabbit Model of Prosthetic Joint Infection.
    Mao Y; Valour F; Nguyen NTQ; Doan TMN; Koelkebeck H; Richardson C; Cheng LI; Sellman BR; Tkaczyk C; Diep BA
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0183220. PubMed ID: 33903108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of IgG and Neutralizing Antibodies against Staphylococcus aureus Alpha-Toxin in Healthy Human Subjects and Diverse Patient Populations.
    Wu Y; Liu X; Akhgar A; Li JJ; Mok H; Sellman BR; Yu L; Roskos LK; Esser MT; Ruzin A
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263109
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification and application of a neutralizing epitope within alpha-hemolysin using human serum antibodies elicited by vaccination.
    Wei J; Cheng X; Zhang Y; Gao C; Wang Y; Peng Q; Luo P; Yang L; Zou Q; Zeng H; Gu J
    Mol Immunol; 2021 Jul; 135():45-52. PubMed ID: 33873093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to capsular polysaccharide and clumping factor A prevent mastitis and the emergence of unencapsulated and small-colony variants of Staphylococcus aureus in mice.
    Tuchscherr LP; Buzzola FR; Alvarez LP; Lee JC; Sordelli DO
    Infect Immun; 2008 Dec; 76(12):5738-44. PubMed ID: 18809660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies against a secreted product of Staphylococcus aureus trigger phagocytic killing.
    Thomer L; Emolo C; Thammavongsa V; Kim HK; McAdow ME; Yu W; Kieffer M; Schneewind O; Missiakas D
    J Exp Med; 2016 Mar; 213(3):293-301. PubMed ID: 26880578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure.
    Hawkins J; Kodali S; Matsuka YV; McNeil LK; Mininni T; Scully IL; Vernachio JH; Severina E; Girgenti D; Jansen KU; Anderson AS; Donald RG
    Clin Vaccine Immunol; 2012 Oct; 19(10):1641-50. PubMed ID: 22896688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Candida albicans Augments Staphylococcus aureus Virulence by Engaging the Staphylococcal
    Todd OA; Fidel PL; Harro JM; Hilliard JJ; Tkaczyk C; Sellman BR; Noverr MC; Peters BM
    mBio; 2019 Jun; 10(3):. PubMed ID: 31164467
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults.
    Yu XQ; Robbie GJ; Wu Y; Esser MT; Jensen K; Schwartz HI; Bellamy T; Hernandez-Illas M; Jafri HS
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective activity of anti-lipoteichoic acid monoclonal antibody in single or combination therapies in methicillin-resistant Staphylococcus aureus-induced murine sepsis models.
    Ohsawa H; Baba T; Enami J; Hiramatsu K
    J Infect Chemother; 2020 May; 26(5):520-522. PubMed ID: 32001173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein.
    Uppalapati SR; Kingston JJ; Murali HS; Batra HV
    Vaccine; 2014 May; 32(25):3075-81. PubMed ID: 24699467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.